The focus of RAPP-ID was the development of rapid diagnostic platforms for infectious diseases, and some of the technologies and resources developed within the project could help speed up the development of rapid diagnostic tests in the future. In an interview with the IMI ...
General Overview Scientific Committee members The IMI Scientific Committee is an advisory group within IMI whose members are top experts from a range of different fields. They are appointed further to suggestions made by the States Representatives Group for a renewable term of ...
General overview EU Member stateS Countries associated to Horizon 2020 The IMI States Representatives Group (SRG) is an advisory group within IMI and consists of representatives from Member States and countries associated with the EU’s research framework programmes. SRG members ...
Privacy Policy Personal data protection The IMI2 JU, like other EU institutions, bodies, agencies and offices (EU institutions), may process your personal data also known as personal information) for a number of reasons, from dealing with public requests for information, staff ...
Feel like you need additional help with your application? Here are some ways to get more support: Contact the IMI Programme Office. If you have additional questions about our funding rules, application procedures, intellectual property policy or Calls for proposals, please ...
After the launch of Call 23 in June 2020 it is foreseen that there will be no further calls launched by IMI2. Therefore, the IMI2 3rd party ideas portal is now closed. A future public private partnership in health is expected to be launched in 2021. Those interested in the plans ...
IMI owes its success to the involvement in its activities of people from industry, universities and research institutes, small and medium-sized enterprises (SMEs), patient groups, regulatory authorities, and others. This page gives a general overview of the different ways you can ...
IMI's BTCure project has generated new insights into the causes and development of rheumatoid arthritis, directing efforts towards earlier detection, prevention and the idea of inducing tolerance to this chronic and debilitating disease. Follow-up research includes new studies to ...